Synopsis
0
KDMF
0
VMF
0
FDA Orange Book
0
Canada
0
Australia
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
79
PharmaCompass offers a list of Chlorhexidine HCl API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Chlorhexidine HCl manufacturer or Chlorhexidine HCl supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Chlorhexidine HCl manufacturer or Chlorhexidine HCl supplier.
PharmaCompass also assists you with knowing the Chlorhexidine HCl API Price utilized in the formulation of products. Chlorhexidine HCl API Price is not always fixed or binding as the Chlorhexidine HCl Price is obtained through a variety of data sources. The Chlorhexidine HCl Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Chlorhexidine Dihydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Chlorhexidine Dihydrochloride, including repackagers and relabelers. The FDA regulates Chlorhexidine Dihydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Chlorhexidine Dihydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Chlorhexidine Dihydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Chlorhexidine Dihydrochloride supplier is an individual or a company that provides Chlorhexidine Dihydrochloride active pharmaceutical ingredient (API) or Chlorhexidine Dihydrochloride finished formulations upon request. The Chlorhexidine Dihydrochloride suppliers may include Chlorhexidine Dihydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of Chlorhexidine Dihydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Chlorhexidine Dihydrochloride DMF (Drug Master File) is a document detailing the whole manufacturing process of Chlorhexidine Dihydrochloride active pharmaceutical ingredient (API) in detail. Different forms of Chlorhexidine Dihydrochloride DMFs exist exist since differing nations have different regulations, such as Chlorhexidine Dihydrochloride USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Chlorhexidine Dihydrochloride DMF submitted to regulatory agencies in the US is known as a USDMF. Chlorhexidine Dihydrochloride USDMF includes data on Chlorhexidine Dihydrochloride's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Chlorhexidine Dihydrochloride USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Chlorhexidine Dihydrochloride suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Chlorhexidine Dihydrochloride Drug Master File in Japan (Chlorhexidine Dihydrochloride JDMF) empowers Chlorhexidine Dihydrochloride API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Chlorhexidine Dihydrochloride JDMF during the approval evaluation for pharmaceutical products. At the time of Chlorhexidine Dihydrochloride JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Chlorhexidine Dihydrochloride suppliers with JDMF on PharmaCompass.
A Chlorhexidine Dihydrochloride CEP of the European Pharmacopoeia monograph is often referred to as a Chlorhexidine Dihydrochloride Certificate of Suitability (COS). The purpose of a Chlorhexidine Dihydrochloride CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Chlorhexidine Dihydrochloride EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Chlorhexidine Dihydrochloride to their clients by showing that a Chlorhexidine Dihydrochloride CEP has been issued for it. The manufacturer submits a Chlorhexidine Dihydrochloride CEP (COS) as part of the market authorization procedure, and it takes on the role of a Chlorhexidine Dihydrochloride CEP holder for the record. Additionally, the data presented in the Chlorhexidine Dihydrochloride CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Chlorhexidine Dihydrochloride DMF.
A Chlorhexidine Dihydrochloride CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Chlorhexidine Dihydrochloride CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Chlorhexidine Dihydrochloride suppliers with CEP (COS) on PharmaCompass.
A Chlorhexidine Dihydrochloride written confirmation (Chlorhexidine Dihydrochloride WC) is an official document issued by a regulatory agency to a Chlorhexidine Dihydrochloride manufacturer, verifying that the manufacturing facility of a Chlorhexidine Dihydrochloride active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Chlorhexidine Dihydrochloride APIs or Chlorhexidine Dihydrochloride finished pharmaceutical products to another nation, regulatory agencies frequently require a Chlorhexidine Dihydrochloride WC (written confirmation) as part of the regulatory process.
click here to find a list of Chlorhexidine Dihydrochloride suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Chlorhexidine Dihydrochloride as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Chlorhexidine Dihydrochloride API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Chlorhexidine Dihydrochloride as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Chlorhexidine Dihydrochloride and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Chlorhexidine Dihydrochloride NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Chlorhexidine Dihydrochloride suppliers with NDC on PharmaCompass.
Chlorhexidine Dihydrochloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Chlorhexidine Dihydrochloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Chlorhexidine Dihydrochloride GMP manufacturer or Chlorhexidine Dihydrochloride GMP API supplier for your needs.
A Chlorhexidine Dihydrochloride CoA (Certificate of Analysis) is a formal document that attests to Chlorhexidine Dihydrochloride's compliance with Chlorhexidine Dihydrochloride specifications and serves as a tool for batch-level quality control.
Chlorhexidine Dihydrochloride CoA mostly includes findings from lab analyses of a specific batch. For each Chlorhexidine Dihydrochloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Chlorhexidine Dihydrochloride may be tested according to a variety of international standards, such as European Pharmacopoeia (Chlorhexidine Dihydrochloride EP), Chlorhexidine Dihydrochloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Chlorhexidine Dihydrochloride USP).
